OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 28, 2021
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
June 29, 2020
Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.
February 01, 2020
Analytical solutions are improving for raw material testing, process development, drug product release, and more.
November 01, 2019
The following details some of the latest tools and systems available for biopharmaceutical laboratory operations.
September 01, 2019
Effective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost.
July 01, 2019
Real-time monitoring of product- and process-related impurities remains a challenge.
April 15, 2019
Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex therapeutic classes.
April 12, 2019
The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.
March 25, 2019
Waters debuted a range of new TA Instruments innovations and the BioAccord System at Pittcon 2019 in Philadelphia, PA, on March 17–21, 2019.
February 01, 2019
Leveraging vast quantities of analytical data requires digitalization and platform integration.